Search
Treatment Settings
Various treatment formats, either in a live-in facility or through regular visits to a clinic, are designed for ongoing support, to help maintain recovery, and to prevent relapse.
Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder
Abstract
Importance Suicidal behavior is a significant clinical concern in individuals with borderline personality disorder (BPD), but the effectiveness of pharmacotherapy on reducing suicide risk has remained unknown.
Objective To...
Continuum of Care in Recovery
ISSUP Botswana present their Webinar on Continuum of Care in Recovery.
Accounts of women identified as drinking at ‘high risk’ during pregnancy
Drinking alcohol during pregnancy is associated with Foetal Alcohol Spectrum Disorders (FASD), and women who drink at higher levels are more likely to have a baby with FASD.
Efforts to better understand and respond to ‘high risk’ drinking...
Webinar on Addiction Prevention for Youth
The International Society of Substance Use Professionals (ISSUP) Indonesia and the Indonesia International Training and Treatment Centre (ITTC) together hosted the second webinar on "Addiction Prevention for Youth" on Sunday, May 21, 2023...
Indonesia's INEP Plus Online Training
ISSUP Indonesia organized the Introduction to Evidence-Based Prevention (INEP) Online Course as a national-level training in Indonesia with 17 participants. The training, conducted by Dr.dr. Kristiana Siste, SpKJ, and Dr. Elvina K...
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 24, 2023
Today, the U.S. Food and Drug Administration (FDA) approved the extended-release Brixadi (buprenorphine) subcutaneous (for use under the skin) injection to treat moderate to severe opioid use disorder...
Covering Substance Use and Addiction Responsibly
Stories about substance use and addiction can be among the thorniest that health and science reporters encounter. This topic carries a long history of marginalizing the people most directly affected. In addition, deeply ingrained societal misconceptions about substance use make it difficult to separate fact from fiction
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Abstract
Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
Assessment of Medical Cannabis and Health-Related Quality of Life
Abstract
Importance The use of cannabis as a medicine is becoming increasingly prevalent. Given the diverse range of conditions being treated with medical cannabis, as well as the vast array of products and dose forms available, clinical...
SMART recovery for youth: a small, exploratory qualitative study examining the potential of a mutual-aid, peer support addictive behaviour change program for young people
Abstract
Background
SMART (Self-Management and Recovery Training) Recovery is a mutual-aid program informed by cognitive behaviour therapy and motivational interviewing that provides support for a range of addictive behaviours. SMART...
Strategies to Address Cocaine and Methamphetamine
Presented by Richard Rawson, PhD, Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont, this presentation provided an overview of the...
Character Strengths and Recovery from Addiction
ISSUP Kenya present their Webinar on Insights from Positive Psychology and Psychology of Religion as applied to treatment and recovery from addiction.
UNODC supported delegations from four Central Asian countries in a high-level study tour to the United Kingdom
The UNODC Regional Office for Central Asia (ROCA) together with the UNODC Prevention, Treatment and Rehabilitation Section (PTRS) organized a study tour for high-level representatives, including senior officials, policymakers and substance...
National Drug Council equipping professionals with capacity to effectively treat substance use disorders in adolescents
Thirty adolescent treatment professionals in St. Kitts and Nevis are this week engaged in a training programme geared towards equipping them with the tools to identify, assess and treat adolescents with substance use disorders.
Buprenorphine versus methadone for the treatment of opioid dependence
Summary
Background
Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and...
Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review
Abstract
Objective
The crisis of opioid use puts a strain on resources in the United States and worldwide. There are 3 US Food and Drug Administration–approved medications for treatment of opioid use disorder: methadone, buprenorphine...
Focal mu-opioid receptor activation promotes neuroinflammation and microglial activation in the mesocorticolimbic system: Alterations induced by inflammatory pain
Abstract
Microglia participates in the modulation of pain signaling. The activation of microglia is suggested to play an important role in affective disorders that are related to a dysfunction of the mesocorticolimbic system (MCLS) and are...
Implementation and workflow strategies for integrating digital therapeutics for alcohol use disorders into primary care: a qualitative study
Abstract
Background
Alcohol use disorders (AUD) are prevalent and often go untreated. Patients are commonly screened for AUD in primary care, but existing treatment programs are failing to meet demand. Digital therapeutics include novel...